Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Crofelemer

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,823Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jaguar Health Reports 4% Revenue Growth In Q3 2025
    Jaguar Health Reports 4% Revenue Growth In Q3 2025

    17 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-17/jaguar-health-reports-third-quarter-2025-financials-net-q3-2025-revenue-up-approximately-4-versus

    PHARMIWEB
    17 Nov 2025
    Share Share
    Jaguar Health Provides Recap of November 8, 2025 Presentation
    Jaguar Health Provides Recap of November 8, 2025 Presentation

    13 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-13/jaguar-health-provides-recap-of-november-8-2025-presentation-on-groundbreaking-results-of-proof-of

    PHARMIWEB
    13 Nov 2025
    Share Share
    Jaguar Health Meets FDA To Advance Crofelemer Trial
    Jaguar Health Meets FDA To Advance Crofelemer Trial

    06 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-06/jaguar-health-completes-meeting-with-fda-for-advice-on-development-pathways-to-advance-ongoing-crofe

    PHARMIWEB
    06 Oct 2025
    Share Share
    FDA Grants Expanded Access for Jaguar’s Crofelemer in MVID
    FDA Grants Expanded Access for Jaguar’s Crofelemer in MVID

    30 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-30/fda-authorized-expanded-access-programs-utilizing-jaguar-healths-novel-crofelemer-powder-for-oral-s

    PHARMAWEB
    30 Sep 2025
    Share Share
    Jaguar Health Gets $250k FDA Grant For Canalevia Trial In Dogs
    Jaguar Health Gets $250k FDA Grant For Canalevia Trial In Dogs

    25 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-25/jaguar-health-receives-notice-of-250-000-fda-grant-to-fund-confirmatory-trial-to-support-fda-approv

    PHARMAWEB
    25 Sep 2025
    Share Share
    Jaguar Health Seeks FDA Orphan Drug Designation for Crofelemer
    Jaguar Health Seeks FDA Orphan Drug Designation for Crofelemer

    24 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-24/jaguar-health-submits-orphan-drug-designation-application-to-fda-for-crofelemer-for-cancer-therapy-r

    PHARMAWEB
    24 Sep 2025
    Share Share